• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Use of Indigenous Bubble CPAP during Swine Flu Pandemic in Pune, India

tetano

Editor, Senior Moderator
Indian J Pediatr. 2011 Mar 26. [Epub ahead of print]
Use of Indigenous Bubble CPAP during Swine Flu Pandemic in Pune, India.

Kinikar A, Kulkarni R, Valvi C, Gupte N.

Department of Pediatrics, B. J. Medical College & Sassoon General Hospital, Pune, M. S-411001, India, aarti.kinikar63@gmail.com.
Abstract

OBJECTIVE: To assess the effectiveness of an indigenously assembled Nasal Bubble CPAP (NB-CPAP) in children during present swine flu pandemic presenting with acute hypoxemic respiratory failure; in improving gas exchange and vital signs; and assess method safety.

METHODS: Thirty Six children with acute hypoxemic respiratory failure admitted to swine flu ICU during the present H1NI pandemic were included (18 confirmed H1N1 positive and 18 confirmed H1N1 negative). After a baseline Arterial Blood Gas, all children received Oxygen via indigenous NB-CPAP Circuit which gave expiratory positive airway pressure of 5 cm water and delivered an FiO(2) of around 70%. Vital signs, pH, PaO(2), PaCO(2), PO(2)/FiO(2) and O(2) saturation were recorded at start and at 6 h into the study.

RESULTS: Median age of the patients was 18 months (58% males, 42% females). Respiratory rate and heart rate improved significantly with indigenous NB-CPAP after 6 h of treatment compared with admission (p < 0.0001 and p < 0.001), respectively. At the end of 6 h on NB-CPAP,PaO(2) (p < 0.0001), PCO(2) (p < 0.0001), PO(2)/FiO(2) (p < 0.0002) and O(2) saturation (p < 0.001) improved significantly. Median duration of NB-CPAP use was 2 days and none required endotracheal intubation. The median hospital stay was 7 days.

CONCLUSIONS: Indigenous NB-CPAP improves hypoxemia and signs and symptoms in hemodynamically stable children with acute respiratory failure due to influenza like illness. It is a cost-effective, safe, well tolerated circuit in highly demanding pandemic situations and may prevent progression to intubation.

PMID: 21442266 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/21442266
 
Back
Top Bottom